Aspen Snaps Up Sigma Pharma Unit In $816M Deal

Law360, New York (August 17, 2010, 2:52 PM EDT) -- Aspen Pharmacare Holdings Ltd. has agreed to shell out AU$900 million ($816 million) to acquire the pharmaceutical business of Australia's Sigma Pharmaceuticals Ltd., a move the South African drug giant said would help expand its footprint in the Asia-Pacific region.

The Sigma unit manufactures and markets prescription, over-the-counter and generic pharmaceutical products and also acts as a wholesale distributor of pharmaceutical and consumer products, Aspen said Monday.

The unit, which is Australia's largest pharmaceutical manufacturer, has about a 25 percent share of the fast-growing Australian generics...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.